Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage

被引:22
作者
Hogan, TH [1 ]
Krebs, FC [1 ]
Wigdahl, B [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA
关键词
C/EBP; HIV-1; monocyte/macrophage;
D O I
10.1080/13550280290167911
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CCAAT/enhancer binding proteins (C/EBPs) are transcription factors that regulate a variety of cellular genes involved in broad range of physiological processes, including immune cell functions that involve cytokine expression and release as well as immune cell differentiation and inflammation. In addition, C/EBP factors regulate many viral promoters, including the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR). The dependence of HIV-1 gene expression and replication on C/EBP factors in cells of myeloid origin positions these factors as important regulators of HIV-1 during the course of disease, because cells of monocyte/macrophage origin are critical components of viral pathogenesis in the peripheral blood and in other tissue compartments, including the central nervous system (CNS). Recent studies also indicate potentially important correlates between HIV-1 LTR C/EBP site sequence variation (which alters factor recruitment and activity), sequence compartmentalization, and the severity of HIV-1-induced immunologic dysfunction and neuropathogenesis. Cumulatively, studies of C/EBP factors and their roles in the regulation of host and viral gene expression indicate the importance of these factors in the progression of HIV-1-associated disease and, specifically, the genesis of CNS disease and HIV-1-associated dementia.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 24 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]   HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors [J].
Ambrosino, C ;
Ruocco, MR ;
Chen, XN ;
Mallardo, M ;
Baudi, F ;
Trematerra, S ;
Quinto, I ;
Venuta, S ;
Scala, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14883-14892
[3]   A novel human CCAAT/enhancer binding protein gene, C/EBP epsilon, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor alpha/delta locus [J].
Antonson, P ;
Stellan, B ;
Yamanaka, R ;
Xanthopoulos, KG .
GENOMICS, 1996, 35 (01) :30-38
[4]   C/EBP-RELATED PROTEIN-2 CONFERS LIPOPOLYSACCHARIDE-INDUCIBLE EXPRESSION OF INTERLEUKIN-6 AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 TO A LYMPHOBLASTIC CELL-LINE [J].
BRETZ, JD ;
WILLIAMS, SC ;
BAER, M ;
JOHNSON, PF ;
SCHWARTZ, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7306-7310
[5]   REGULATED EXPRESSION OF 3 C/EBP ISOFORMS DURING ADIPOSE CONVERSION OF 3T3-L1 CELLS [J].
CAO, ZD ;
UMEK, RM ;
MCKNIGHT, SL .
GENES & DEVELOPMENT, 1991, 5 (09) :1538-1552
[6]   IG/EBP (C/EBP-GAMMA) IS A TRANSDOMINANT NEGATIVE INHIBITOR OF C/EBP FAMILY TRANSCRIPTIONAL ACTIVATORS [J].
COOPER, C ;
HENDERSON, A ;
ARTANDI, S ;
AVITAHL, N ;
CALAME, K .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4371-4377
[7]   CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells [J].
Henderson, AJ ;
Calame, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8714-8719
[8]   C/EBP PROTEINS ACTIVATE TRANSCRIPTION FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN MACROPHAGES MONOCYTES [J].
HENDERSON, AJ ;
ZOU, X ;
CALAME, KL .
JOURNAL OF VIROLOGY, 1995, 69 (09) :5337-5344
[9]   C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines [J].
Henderson, AJ ;
Connor, RI ;
Calame, KL .
IMMUNITY, 1996, 5 (01) :91-101
[10]  
HOGAN TH, 2003, IN PRESS J NEUROVIRO, V9